MBA Geek

Interesting article about the drug industry in the US, following what’s happening with Obama’s health bill. It seems like drug companies are on to a winner, regardless of whether they’re making Swine Flu pills or the world’s best thermogenic fat burner. Here’s how an analyst sees it:

“It could potentially add an additional 32 million lives with prescription drug coverage although some of this benefit will likely be offset by lower pricing,”

There’s an interesting look at the industry in the article, including a comparison with the German health market. Well worth reading if you’re working in the health industry.